Close Menu

NEW YORK – The Centers for Medicare and Medicaid Services and the US Departments of Labor and the Treasury on Saturday issued guidance requiring private health insurance to cover, at no cost, diagnostic testing for SARS-CoV-2, the coronavirus that causes COVID-19.

The guidance covers molecular-based testing, as well as serology tests.

Under the guidance, group health plans and group and individual health insurers must cover diagnostic testing and "certain related items and services" during a medical visit without any cost sharing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.